Welcome to our dedicated page for National Health SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
National HealthCare Corporation’s filings rarely stop at numbers—they reveal how Medicare rate shifts, facility occupancy, and labor costs shape one of America’s largest post-acute care networks. If you have ever asked, “How do I track National HealthCare Corporation insider trading Form 4 transactions?” or searched for a “National HealthCare Corporation quarterly earnings report 10-Q filing,” this page brings every disclosure together—with context that matters.
Stock Titan’s AI reviews each 10-K, 10-Q, 8-K, proxy, and Form 4 within seconds of its EDGAR release. Our summaries turn intricate reimbursement footnotes into plain language, so understanding National HealthCare Corporation SEC documents with AI becomes straightforward. Need real-time alerts? We surface each National HealthCare Corporation Form 4 insider transactions real-time alongside concise commentary on buying or selling trends.
Here is what you will uncover:
- Annual report 10-K simplified: drill into facility occupancy, CMS revenue exposure, and lease commitments without scanning 300 pages.
- Quarterly earnings report filing analysis: compare therapy hours, wage inflation, and cash flow quarter over quarter.
- 8-K material events explained: instant clarity on acquisitions, rate updates, or pandemic-related guidance changes.
- Executive stock transactions Form 4: see whether leadership is accumulating or trimming shares.
- Proxy statement executive compensation: evaluate pay-for-performance metrics tied to occupancy and quality ratings.
Whether you monitor dividend sustainability or compliance risk, our platform keeps National HealthCare Corporation SEC filings explained simply. Save research hours, spot trends earlier, and make decisions with confidence.
National Healthcare Corp. (NHC) Form 4 filing dated 06/26/2025 reports a Code G gift by Sr. VP Patient Services Vicki L. Dodson.
Dodson transferred 788 common shares at $0, lowering her direct holdings from 9,748.5455 to 8,960.5455 shares. No cash sale occurred.
The filing also lists existing equity incentives:
- 3,734 options exercisable at $53.94 (expire 03/08/2028)
- 12,000 options at $94.10 (expire 03/05/2029)
- 13,500 options at $90.62 (expire 02/24/2030)
No other changes to ownership or control were disclosed. Given the small share count and gift classification, investment impact is minimal.